KR101058893B1 - L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산방법 - Google Patents
L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산방법 Download PDFInfo
- Publication number
- KR101058893B1 KR101058893B1 KR1020090018127A KR20090018127A KR101058893B1 KR 101058893 B1 KR101058893 B1 KR 101058893B1 KR 1020090018127 A KR1020090018127 A KR 1020090018127A KR 20090018127 A KR20090018127 A KR 20090018127A KR 101058893 B1 KR101058893 B1 KR 101058893B1
- Authority
- KR
- South Korea
- Prior art keywords
- sucrose
- amino acid
- escherichia
- microorganism
- pts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 58
- 150000008575 L-amino acids Chemical class 0.000 title claims abstract description 49
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 229930006000 Sucrose Natural products 0.000 claims abstract description 145
- 239000005720 sucrose Substances 0.000 claims abstract description 145
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 144
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 54
- 241000588722 Escherichia Species 0.000 claims abstract description 27
- 230000005415 magnetization Effects 0.000 claims abstract description 27
- 102000004190 Enzymes Human genes 0.000 claims abstract description 26
- 108090000790 Enzymes Proteins 0.000 claims abstract description 26
- 230000000694 effects Effects 0.000 claims abstract description 7
- 230000001419 dependent effect Effects 0.000 claims abstract description 6
- 108091000080 Phosphotransferase Proteins 0.000 claims abstract description 5
- 102000020233 phosphotransferase Human genes 0.000 claims abstract description 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 34
- 241000588724 Escherichia coli Species 0.000 claims description 24
- 241000588747 Klebsiella pneumoniae Species 0.000 claims description 24
- 239000004473 Threonine Substances 0.000 claims description 20
- 229960002898 threonine Drugs 0.000 claims description 20
- 108010093591 phosphoenolpyruvate-sucrose phosphotransferase Proteins 0.000 claims description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 101710122939 Sucrose porin Proteins 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 9
- 108700015396 E coli cscB Proteins 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 5
- 101710161955 Mannitol-specific phosphotransferase enzyme IIA component Proteins 0.000 claims description 3
- 230000002103 transcriptional effect Effects 0.000 claims description 3
- 235000013824 polyphenols Nutrition 0.000 claims 1
- 241000488157 Escherichia sp. Species 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 20
- 108090000156 Fructokinases Proteins 0.000 description 19
- 102000003793 Fructokinases Human genes 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 15
- 239000002609 medium Substances 0.000 description 14
- 102100033393 Anillin Human genes 0.000 description 12
- 241000588701 Pectobacterium carotovorum Species 0.000 description 9
- 101150030355 scrB gene Proteins 0.000 description 9
- 101150110242 scrR gene Proteins 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 101150094428 scrA gene Proteins 0.000 description 8
- 101150086685 scrY gene Proteins 0.000 description 8
- 241000588698 Erwinia Species 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 108091033319 polynucleotide Proteins 0.000 description 7
- 239000002157 polynucleotide Substances 0.000 description 7
- 102000040430 polynucleotide Human genes 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 241001646716 Escherichia coli K-12 Species 0.000 description 6
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 6
- 238000003752 polymerase chain reaction Methods 0.000 description 6
- 241001244729 Apalis Species 0.000 description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 5
- WQQSIXKPRAUZJL-UGDNZRGBSA-N Sucrose 6-phosphate Natural products O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 WQQSIXKPRAUZJL-UGDNZRGBSA-N 0.000 description 5
- 108700019146 Transgenes Proteins 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- PJTTXANTBQDXME-UGDNZRGBSA-N sucrose 6(F)-phosphate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 PJTTXANTBQDXME-UGDNZRGBSA-N 0.000 description 5
- 101710173142 Beta-fructofuranosidase, cell wall isozyme Proteins 0.000 description 4
- 108090000604 Hydrolases Proteins 0.000 description 4
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- 108090000301 Membrane transport proteins Proteins 0.000 description 3
- 102000003939 Membrane transport proteins Human genes 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 229940096118 ella Drugs 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 108091008023 transcriptional regulators Proteins 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 3
- 229960004295 valine Drugs 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004254 Ammonium phosphate Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 101100138542 Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) phbH gene Proteins 0.000 description 2
- 101100299477 Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) phbI gene Proteins 0.000 description 2
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- 239000006154 MacConkey agar Substances 0.000 description 2
- FCXZBWSIAGGPCB-YFKPBYRVSA-N O-acetyl-L-homoserine Chemical compound CC(=O)OCC[C@H]([NH3+])C([O-])=O FCXZBWSIAGGPCB-YFKPBYRVSA-N 0.000 description 2
- GNISQJGXJIDKDJ-YFKPBYRVSA-N O-succinyl-L-homoserine Chemical compound OC(=O)[C@@H](N)CCOC(=O)CCC(O)=O GNISQJGXJIDKDJ-YFKPBYRVSA-N 0.000 description 2
- 101710116435 Outer membrane protein Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 2
- 235000019289 ammonium phosphates Nutrition 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 101150018392 cscA gene Proteins 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 101150045242 ptsH gene Proteins 0.000 description 2
- 101150118630 ptsI gene Proteins 0.000 description 2
- 101150009538 scrK gene Proteins 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000588694 Erwinia amylovora Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000322995 Escherichia coli KO11FL Species 0.000 description 1
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 1
- 101100061504 Escherichia coli cscB gene Proteins 0.000 description 1
- 101100309698 Escherichia coli cscK gene Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000017033 Porins Human genes 0.000 description 1
- 108010013381 Porins Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 101710117283 Sucrose permease Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 101150091121 cscR gene Proteins 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/26—Klebsiella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
조성물 | 농도 (리터당) |
수크로오스 | 70 g |
KH2PO4 | 2 g |
(NH4)2SO4 | 25 g |
MgSO4·7H2O | 1 g |
FeSO4·7H2O | 5 mg |
MnSO4·4H2O | 5 mg |
효모 추출물 | 2 g |
탄산칼슘 | 30 g |
pH | 6.8 |
글루코오스 (70 g/L) | 수크로오스 (70 g/L) | |||
OD | L-쓰레오닌(g/L) | OD | L-쓰레오닌(g/L) | |
ABA5G | 14.7 | 21.5 | - | - |
ABA5G/pAscrEC | 14.4 | 21.6 | 8.4 | 12.2 |
ABA5G/pAscrKP | 14.6 | 21.2 | 15.0 | 26.5 |
Claims (8)
- L-아미노산 생산능 및 수크로오스 PTS(phosphoenolypyruvate dependent sucrose phosphotransferase system) 활성을 갖는, 수크로오스 비자화성(non-assimilative) 에스케리시아(Escherichia) 속 미생물에 클렙시엘라 뉴모니애(Klebsiella pneumoniae)에서 유래된 프럭토키나아제, 수크로오스 포린, 수크로오스 PTS 퍼미아제, 수크로오스 히드롤라아제, 및 수크로오스 전사 조절자를 코딩하는 유전자를 도입하여 수득되고, 상기 수크로오스 PTS는 효소 I(EI), 히스티딘 단백질(Histidine protein), 및 글루코오스 특이적 효소 IIA(EIIAcrrGlc , EII)로 구성된 것인 수크로오스 자화성 및 L-아미노산 생산능을 갖는 에스케리시아 속 미생물로서, 상기 에스케리시아 속 미생물은 대장균 CA03-0207(KCCM 10993)인 것인 에스케리시아 속 미생물.
- 삭제
- 삭제
- 삭제
- 삭제
- 제1항에 있어서, 상기 L-아미노산은 L-쓰레오닌인 것인 에스케리시아 속 미생물.
- 제1항에 따른 에스케리시아 속 미생물을 수크로오스를 탄소원으로 포함하는 배지에서 배양하는 단계, 및상기 배양액으로부터 L-아미노산을 회수하는 단계를 포함하는, L-아미노산을 생산하는 방법.
- 제7항에 있어서, 상기 L-아미노산은 L-쓰레오닌인 것인 방법.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090018127A KR101058893B1 (ko) | 2009-03-03 | 2009-03-03 | L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산방법 |
CN201080014196.XA CN102365363B (zh) | 2009-03-03 | 2010-02-16 | 产生l-氨基酸的微生物和利用其生产l-氨基酸的方法 |
BRPI1013673-8A BRPI1013673B1 (pt) | 2009-03-03 | 2010-02-16 | Microorganismo que produz l-aminoácido e método para a produção de l-aminoácido usando o mesmo |
PCT/KR2010/000932 WO2010101359A2 (ko) | 2009-03-03 | 2010-02-16 | L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산 방법 |
EP10748903.1A EP2405005B1 (en) | 2009-03-03 | 2010-02-16 | Microorganism which produces l-amino acid and method for producing l-amino acid using the same |
US13/254,072 US8623620B2 (en) | 2009-03-03 | 2010-02-16 | Microorganism which produces L-amino acid and method for producing L-amino acid using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090018127A KR101058893B1 (ko) | 2009-03-03 | 2009-03-03 | L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100099571A KR20100099571A (ko) | 2010-09-13 |
KR101058893B1 true KR101058893B1 (ko) | 2011-08-23 |
Family
ID=42710079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090018127A Active KR101058893B1 (ko) | 2009-03-03 | 2009-03-03 | L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산방법 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8623620B2 (ko) |
EP (1) | EP2405005B1 (ko) |
KR (1) | KR101058893B1 (ko) |
CN (1) | CN102365363B (ko) |
BR (1) | BRPI1013673B1 (ko) |
WO (1) | WO2010101359A2 (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8222000B2 (en) | 2010-12-06 | 2012-07-17 | E I Du Pont De Nemours And Company | Recombinant bacteria having the ability to metabolize sucrose |
US8129170B1 (en) | 2010-12-06 | 2012-03-06 | E.I. Du Pont De Nemours And Company | Recombinant bacteria having the ability to metabolize sucrose |
KR101261147B1 (ko) * | 2011-01-18 | 2013-05-06 | 씨제이제일제당 (주) | L-아미노산의 생산능이 향상된 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법 |
KR101327093B1 (ko) | 2012-01-06 | 2013-11-07 | 씨제이제일제당 (주) | L-아미노산을 생산할 수 있는 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법 |
US8686114B2 (en) | 2012-03-05 | 2014-04-01 | E I Du Pont De Nemours And Company | Variant sucrose transporter polypeptides |
KR20140102393A (ko) * | 2013-02-13 | 2014-08-22 | 씨제이제일제당 (주) | L-쓰레오닌 생산능을 가지는 재조합 에스케리키아 속 미생물 및 이를 이용한 l-쓰레오닌의 생산방법 |
US11926858B2 (en) | 2014-06-27 | 2024-03-12 | Glycom A/S | Oligosaccharide production |
ES3002778T3 (en) * | 2014-06-27 | 2025-03-07 | Glycom As | Oligosaccharide production |
KR102078732B1 (ko) | 2015-11-09 | 2020-02-19 | 케세이 알&디 센터 코퍼레이션 리미티드 | 변형된 막 투과성 |
KR101991206B1 (ko) * | 2018-11-29 | 2019-06-19 | 씨제이제일제당 (주) | cAMP 수용 단백질 변이체 및 이를 이용한 L-아미노산 제조방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610836B1 (en) * | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
RU2212447C2 (ru) * | 2000-04-26 | 2003-09-20 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" | Штамм escherichia coli - продуцент аминокислоты (варианты) и способ получения аминокислот (варианты) |
ES2331956T3 (es) | 2004-01-30 | 2010-01-21 | Ajinomoto Co., Inc. | Microorganismo que produce l-aminoacidos y procedimiento para producir l-aminoacidos. |
KR100576342B1 (ko) * | 2004-02-05 | 2006-05-03 | 씨제이 주식회사 | galR 유전자가 불활성화된 L-쓰레오닌 생성 미생물,그를 제조하는 방법 및 상기 미생물을 이용한L-쓰레오닌의 제조방법 |
EP1928899B1 (en) * | 2005-09-27 | 2012-10-24 | Ajinomoto Co., Inc. | An l-amino acid-producing bacterium and a method for producing an l-amino acid |
JP2007117082A (ja) | 2005-09-27 | 2007-05-17 | Ajinomoto Co Inc | L−アミノ酸生産菌及びl−アミノ酸の製造法 |
-
2009
- 2009-03-03 KR KR1020090018127A patent/KR101058893B1/ko active Active
-
2010
- 2010-02-16 CN CN201080014196.XA patent/CN102365363B/zh active Active
- 2010-02-16 EP EP10748903.1A patent/EP2405005B1/en active Active
- 2010-02-16 WO PCT/KR2010/000932 patent/WO2010101359A2/ko active Application Filing
- 2010-02-16 US US13/254,072 patent/US8623620B2/en active Active
- 2010-02-16 BR BRPI1013673-8A patent/BRPI1013673B1/pt active IP Right Grant
Non-Patent Citations (1)
Title |
---|
SHARON J. REID 등. Sucrose utilisation in bacteria: genetic organisation and regulation. Appl Microbiol Biotechnol. 2005, vol. 67, no. 3, pp. 312-321* |
Also Published As
Publication number | Publication date |
---|---|
CN102365363B (zh) | 2014-05-14 |
EP2405005A9 (en) | 2014-10-22 |
US20120122163A1 (en) | 2012-05-17 |
US8623620B2 (en) | 2014-01-07 |
EP2405005A2 (en) | 2012-01-11 |
EP2405005B1 (en) | 2018-09-19 |
CN102365363A (zh) | 2012-02-29 |
KR20100099571A (ko) | 2010-09-13 |
BRPI1013673B1 (pt) | 2024-03-05 |
WO2010101359A2 (ko) | 2010-09-10 |
BRPI1013673A2 (pt) | 2015-08-25 |
WO2010101359A3 (ko) | 2010-12-09 |
EP2405005A4 (en) | 2014-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101058893B1 (ko) | L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산방법 | |
JP5486029B2 (ja) | 遺伝子増幅によるリジン産生の増加 | |
US10934565B2 (en) | Method of producing succinic acid and other chemicals using facilitated diffusion for sugar import | |
DK2239336T3 (en) | Microorganism for Preparation of L-Amino Acids and Process for Preparation of L-Amino Acids Using the Same | |
CN103215291B (zh) | 用于生产l-2-氨基丁酸的载体、工程菌株及方法 | |
RU2215782C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ L-АМИНОКИСЛОТ, ШТАММ Escherichia coli - ПРОДУЦЕНТ L-АМИНОКИСЛОТЫ (ВАРИАНТЫ) | |
BR112013014688B1 (pt) | Bactérias escherichia coli geneticamente alteradas | |
KR101058894B1 (ko) | L-아미노산 생산 미생물 및 이를 이용한 l-아미노산 생산방법 | |
CN109486834B (zh) | 高产乳酸链球菌素的重组乳酸乳球菌及构建方法 | |
CN116676243A (zh) | 产2'-岩藻糖基乳糖的重组大肠杆菌的构建方法及其应用 | |
Boël et al. | Catabolite Regulation of the Cytochrome c~ 5~ 5~ 0-Encoding Bacillus subtilis cccA Gene | |
CN115572704A (zh) | 重组微生物及其构建方法和应用 | |
CN115572703A (zh) | 重组菌株及其生产氨基酸的方法 | |
US20030219865A1 (en) | Novel regulatory elements of cold-inducible hutU gene from the Antarctic psychrotrophic bacterium Pseudomonas Syringae | |
CN115572717A (zh) | L-苏氨酸生产菌株及其构建方法与应用 | |
CN115612680A (zh) | 生产苏氨酸的重组微生物、其构建方法及其生产苏氨酸的方法 | |
Blatch | Molecular analysis of the Vibrio alginolyticus sucrose utilization system cloned into Escherichia coli | |
Jeong | Construction of a Novel Recombinant Escherichia coli Strain Capable of Simultaneously Utilizing Glucose and Xylose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20090303 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20101103 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20110725 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20110817 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20110818 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20140603 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20140603 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150527 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20150527 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160530 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20160530 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180528 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20180528 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190527 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20190527 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20200525 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20210525 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20220525 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20230524 Start annual number: 13 End annual number: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20240522 Start annual number: 14 End annual number: 14 |